ARKK vs ATAI
ARK Innovation ETF (ARKK) versus ATAI Life Sciences BV (ATAI) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
ARKK currently screens at market cap $0. ATAI currently screens at market cap $555.8M.
Not investment advice. Open the ARKK and ATAI stock pages for the full models.
Not investment advice.